Moolec Science SA [MLEC] stock is trading at $0.25, down -4.18%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MLEC shares have gain 9.93% over the last week, with a monthly amount drifted -39.11%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Moolec Science SA [NASDAQ: MLEC] stock has seen the most recent analyst activity on September 27, 2023, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $5.
Moolec Science SA [MLEC] stock has fluctuated between $0.21 and $10.47 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Moolec Science SA [NASDAQ: MLEC] shares were valued at $0.25 at the most recent close of the market. An investor can expect a potential return of 1100.0% based on the average MLEC price forecast.
Analyzing the MLEC fundamentals
Moolec Science SA [NASDAQ:MLEC] reported sales of 7.83M for the trailing twelve months, which represents a growth of 948.32%. Gross Profit Margin for this corporation currently stands at -0.16% with Operating Profit Margin at -0.99%, Pretax Profit Margin comes in at -0.97%, and Net Profit Margin reading is -1.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -1.02 and Total Capital is -0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of7.9.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2268 points at the first support level, and at 0.1989 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2787, and for the 2nd resistance point, it is at 0.3027.
Ratios To Look Out For
For context, Moolec Science SA’s Current Ratio is 1.48. Further, the Quick Ratio stands at 0.73, while the Cash Ratio is 0.3. Considering the valuation of this stock, the price to sales ratio is 0.35, the price to book ratio is 0.36.
